Catch Our CEO, Sam Zamarripa, as a panelist for the SEMDA Southeastern Medical Device Association MedTech Conference this weekend in Greenville, SC! Thursday at 2:30 PM. Hear Sam speak in the breakout session "The Opioid Crisis and Technology's Role in Solving It." He will be discussing how technology can be used when an opioid is prescribed to reduce misuse, abuse, addiction, and death.
FOR IMMEDIATE RELEASE
Contact: Sam Zamarripa
INTENT SOLUTIONS™ HIRES CHIEF TECHNOLOGY OFFICER
John Kidd Will Provide Technical Direction to Impact User Experience
"Intent Solutions has a massive sea of opportunity"
-John Kidd, Chief Technology Officer
ATLANTA (March 15, 2018) – Intent Solutions™, creator of the breakthrough medical device technology TAD™, is excited to announce the addition of its new Chief Technology Officer, John Kidd. An accomplished technology executive with experience including researching, developing, and implementing technology solutions deployed at multiple Fortune 100 companies, Kidd has a proven track record in developing enterprise software applications for startup and high-growth companies that benefit the businesses bottom-line while addressing customer needs.
TAD, for “Take As Directed,” is a smart, mobile, medication dispenser that assists patients in obtaining better health outcomes by helping the right patient take the right dose at the right time.
“Intent Solutions has a big opportunity in the market and the looming opioid crisis is in need of some good solutions,” said Kidd. “I believe that Intent Solutions is developing technology that will create unprecedented visibility and accountability across all responsible parties from drug manufacturer to distributor to payer to patient. Ultimately, we will shine a light on where the issues are happening and enable early detection of abuse and diversion.”
At Intent Solutions, Kidd will help to provide a clear path for solutions that will impact the company’s customer base.
“Intent Solutions has a massive sea of opportunity,” said Kidd. “Providing technology solutions where we can extract and see commonalities, we will be able to find new product opportunities within this large market space not only moving forward with TAD, but possibly other products that fit our customer’s needs.”
For more information, visit www.IntentSolutions.com
or contact email@example.com
Sam Zamarripa, CEO of Intent Solutions, spoke with Adina Soloman from Crain's Atlanta about our innovative pill-dispensing technology. The article discusses how it can be used to combat the Opioid Crisis. Sam said that "an open bottle is basically an invitation to take more medicine than you need." Innovative technology can improve adherence and that is the goal with TAD; to improve the safety and intended use of medications.
To read more:
ATLANTA (February 28, 2018) - Intent Solutions™ is proud to announce Hania Rios as our new Marketing Intern! Hania is currently a senior Marketing Student at Georgia State University and will be graduating in May. She is an Atlanta native and has a background in retail sales and content creation. When she is not in school or working, she is traveling, taking cycling classes, or modeling.
“Hania will be helping maintain our social media channels and creating various marketing materials," said Sam Zamarripa, Intent Solutions CEO. We are delighted to have the chance to work with her at this moment in her career.
We hope you are as pleased as we are to welcome Hania to the team!
This week Closer Look launched a new series highlighting local startups that are trying to address social, economic and health issues.
We kick-off the series with the Atlanta-based startup, Intent Solutions, which has created a device, TAD, to help curb the opioid epidemic.
The company’s founder, and former Georgia state senator, Sam Zamarripa explains how patients and doctors can use the TAD device, which stands for “take as directed” to monitor prescription medication intake.
Intent Solutions has developed an innovative technology and data solution designed to improve adherence in pharmaceutical clinical trials, chronic pain management, and specialty pharmacy. Today the company is poised to take on the final frontier of medication compliance, making sure the right patient takes the right dose at the right time. Central to this ambition is the company’s portable medication dispenser aptly named, tad™, for “Take as Directed.” We talked with the CEO of Intent Solutions, Sam Zamarripa to get some insight into their plans for 2018.
Medication adherence is a serious issue for care providers — especially in light of recent statistics that show drug overdoses deaths are now the leading cause of accidental death in the U.S., surpassing automobile accidents, guns, and HIV. It’s important for doctors to track the prescriptions they’re doling out, especially of potentially-addictive medications like painkillers.
One Atlanta startup is helping healthcare providers maintain control over prescriptions by bringing smart connections to prescriptions. Intent Solutions, a company in the Advanced Technology Development Center (ATDC) portfolio, is tackling the market with a cloud-connected device that dispenses prescriptions only in certain amounts and at certain times.
Intent Solutions™, creator of the breakthrough medical device technology, tad™, has rounded out its executive team in preparation for going commercial later this year, which puts the company in a promising position to address the ongoing national opioid crisis. The commercialization efforts follow the company's successful $1.5 million seed round capital raise in 2016.
Posted: 2:02 p.m. Monday, October 16, 2017
An Atlanta-based start-up is preparing to launch a business aimed at providing dispensing devices that make it harder for patients to overuse opioid painkillers.
Intent Solutions will begin selling its TAD – “Take as Directed” – device in December, officials said.
The product is a response to a widespread, national crisis that some argue was sparked by over-enthusiastic marketing and prescribing of opioid medicines.
ATLANTA (August 30, 2017) – Intent Solutions™, creator of the breakthrough medical device technology tad™, is excited to announce the addition of its new Chief Strategy Officer, Paul Quiner. Paul has spent his career in healthcare both from product and service perspectives. “Paul brings extensive experience in business including strategy, mergers and acquisitions experience,” said Sam Zamarripa, CEO. “In addition we believe that Paul’s legal training will give him a unique perspective on our regulatory issues at both the state and federal level.”
INTENT SOLUTIONS™ HIRES CHIEF OPERATING OFFICER Ward Broom Will Oversee Strategy to Bring TAD™ to the Commercial Market
ATLANTA (June 23, 2017) – Intent Solutions™, creator of the breakthrough medical device technology TAD™, is excited to announce the addition of its new Chief Operating Officer, Ward Broom. With a background of co-founding a healthcare business, Broom’s experience includes taking a product from development to an exit. Broom has two degrees from the Georgia Institute of Technology and is currently completing his MBA there with a focus in management of technology, getting up to speed with the latest practices in business management.
“I was originally drawn to the Intent Solutions team because of their leadership and passion for the product,” said Broom. “TAD is poised for commercialization, and I enjoy the start up community and challenges that it presents. The idea of taking another healthcare product that has the potential to benefit the community and medical research field and helping to commercialize and make it a reality is very exciting.”
TAD, for “Take As Directed,” is a smart, mobile, medication dispenser that helps patients obtain better health outcomes by helping the right patient take the right dose at the right time.
At Intent Solutions, Broom will develop the operational strategies for the organization as it gains customers and ramps up for growth. Focusing on the internal processes including customer interfacing, implementations, and product management, Broom will be an asset for Intent Solutions as it moves forward into a new phase of growth.
For more information, visit www.IntentSolutions.com
or contact firstname.lastname@example.org
Last week we had a great opportunity to interview Jacob Levenson, CEO of Map Health Management, of Austin, Texas. We focused our conversation on the importance of technology and data in population health---understanding where we are coming from and where we’re are going with this sea of data!
Going to HIMSS '17 in Orlando? On Monday February 20th, Tyler McCrary will be at MAP Health Management's booth, 6744. Come by to see a demonstration of TAD and hear about our partnership with MAP Health.
ANNOUNCEMENT: MAP Announces Partnership with Intent Solutions to Assess Medication Compliance in Patients with Addiction
MAP ANNOUNCES PARTNERSHIP WITH INTENT SOLUTIONS TO ASSESS MEDICATION COMPLIANCE IN PATIENTS WITH ADDICTION
MAP Health Management, LLC., announced today a partnership with Intent Solutions designed to track adherence to medication protocols for patients with a Substance Use Disorder diagnosis who are served by MAP’s patient engagement technology. Intent Solutions is the creator of the TAD™, a biometric pill dispensation device that can track in real-time who has or has not taken their medication.
The partnership will launch with a pilot program as early as March of this year wherein a number of patients whose risk for relapse is continuously measured by MAP’s technology will be provided a TAD™ device. The device will send real-time data to MAP’s platform when a patient takes their medication, or fails to do so. With this information, MAP can inform the appropriate members of collaborative care networks if a patient is overusing their medication, or failing to take their medication at all. This information is then leveraged to improve clinical outcomes and manage financial risk through facilitating early interventions and other modes of mitigating recidivism and costly treatment episodes.
INTENT SOLUTIONS™ ANNOUNCES NEW ADVISORY BOARD MEMBER
David R. Gastfriend, M.D. to Bring Pharma-Tech Knowledge
ATLANTA (January 17, 2017) – Intent Solutions™, creator of the breakthrough medical device technology TAD™, is excited to announce the appointment of David R. Gastfriend, M.D., chief architect of CONTINUUM, the American Society of Addiction Medicine’s standardized treatment software, to its Advisory Board. Gastfriend brings a vast wealth of pharma-tech experience from his work at Alkermes, Inc., where he supported gaining FDA approval of VIVITROL® for the treatment of alcohol and opioid dependence. Most recently, Gastfriend co-founded DynamiCare Health, Inc., a technology start-up that focuses on incentivizing patients for compliance on treatments. As a clinical scientist in addiction, he will assist in helping Intent Solutions optimize TAD for improving patient adherence, as well as advise the company on leveraging the various stakeholders in the healthcare system to achieve change and improvements in patient outcomes.
Clinical Trials Insight: "Adherence Data Gets Smart"
The very definition of is on the brink of change because of new technologies, sensors and real-time data. Intent Solutions is a part of a major shift in the digital health economy where the ability to monitor and stream vast sets of new, real-time data in clinical research and health delivery will reveal how and when people take medications.
Intent Solutions Looks to Expand Market
DECEMBER 6, 2016 BY KATHY DION
ATLANTA – With $1.5 million in new funding on the books, Intent Solutions aims to expand the market for its TAD smart medication dispenser technology.
TAD has been attracting attention from big specialty pharmaceutical companies recently and Sam Zamarripa, president/director of Intent Solutions, hopes to work with them on clinical research to expand the market for the device.
INTENT SOLUTIONS™ RAISES $1.5 MILLION IN SEED CAPITAL
Announces first equity round of financing to drive growth in 2017
ATLANTA (November 11, 2016) – Intent Solutions™, creator of the breakthrough medical device technology TAD™, announced today that is has successfully completed a seed round of funding of $1.5 million.
TAD, for “Take As Directed,” is a smart, mobile, medication dispenser that helps patients obtain better health outcomes by helping the right patient take the right dose at the right time. TAD, which can be programmed to a specific regimen and schedule, incorporates biometric access and is fully tamper resistant. The medication dispenser also records adherence data, which is sent to a cloud database for analysis, reducing errors and simplifying data reconciliation for clinical trials.
Intent Solutions raises $1.5M for connected device aimed at medication adherence, abuse prevention
By Jonah Comstock | November 14, 2016
Intent Solutions, an Atlanta-based company working on a connected medication dispenser called TAD, has raised $1.5 million in seed funding. The company did not disclose the investors.
INTENT SOLUTIONS™ ANNOUNCES NEW ADVISORY BOARD MEMBER
Chris Hassan to Bring Vast Patient Care and Treatment Knowledge
ATLANTA (October 19, 2016) – Intent Solutions™, creator of the breakthrough medical device technology TAD™, is excited to announce the appointment of Chris Hassan, previous CEO at Colonial Management Group, LP, to its Advisory Board. Hassan brings a vast wealth of knowledge from his years overseeing the treatment and medication of tens of thousands of patients with opioid use disorder at Colonial Management Group, LP. Moreover, Hassan has been on the front edge of drug development for major pharmaceuticals including Depot Naltrexone, as well as the commercial introduction of Buprenorphine in the US, which is now the standard of care in office based opioid treatment. As an expert on drug abuse science, he will advise Intent Solutions on issues including TADs ability to help treat opioid use disorder.